CIK 0001528115 · Non-accelerated filer<br>Smaller reporting company
Annexon, Inc.
Sign in to watch- Ticker
- ANNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 275414423
- Phone
- (650) 822-5500
- Business address
- 1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Regulation FD disclosure
- 4 Planned sale EVP & Chief Innovation Officer sold 21,000 shares at $4.52 ($94,966)
- 4 Open-market buy Director bought 350,000 shares at $2.88 ($1,008,000)
- 144 Insider Sale of Securities
- 8-K/A Event Material agreement · Other events
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- FWP Offering Free Writing Prospectus
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Other events
- 8-K Event Other events
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Regulation FD disclosure · Other events
Page 14 of 27 · 524 filings